Atlas Trials

Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients

Clinical trial NCT04223596 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04223596
Sponsor
Fundación GECP
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Lung CancerNSCLCNSCLC Stage IIIBNSCLC Stage IV
Start date
2020-05-04
Primary completion
2026-11-30
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.